Assessment of ART knowledge and adherence to ARVs among PLWHA accessing care in two Nigerian Military HIV/AIDS Treatment sites

Authors

  • David Ufuoma Adje Delta State University, Abraka, Nigeria , http://orcid.org/0000-0002-4196-2703 (unauthenticated)
  • Felicia Esemekiphorar Williams Dept. of Clinical pharmacy and pharmacy practice, University of Ilorin, Nigeria ,
  • Chukwuka Nicholas Bezugbe Naval Hospital, Lagos ,
  • Dauda Audi Dangiwa Dept. of Clinical Pharmacy and Pharmacy Practice, University of Jos, Jos, Nigeria ,

DOI:

https://doi.org/10.30442/ahr.0401-1-06

Keywords:

Adherence, antiretroviral medicines, Antiretroviral therapy, Knowledge, Nigeria, HIV

Abstract

Background:       Adherence to Highly Active Antiretroviral Therapy (HAART) is critical in achieving treatment goals, avoiding antimicrobial resistance, preventing treatment failure and improving the patient’s quality of life.

Objectives: To assess the knowledge of antiretroviral therapy (ART) and adherence to antiretroviral (ARVs) medicines amongst People Living With HIV/AIDS (PLWHA) accessing care in two Nigerian Military HIV/AIDS Treatment sites.

Methods: Four hundred patients on HAART who visited the study sites during the study period were recruited for the study using systematic random sampling method. A semi-structured, pretested, interviewer-administered questionnaire was used to obtain demographic details. Patients’ knowledge of HIV was assessed using an 8-item questionnaire while adherence was measured using the Simplified Medication Adherence Questionnaire (SMAQ).

Results: The predominant age group was 31-40 years (46.4%). There were more females (69%) than males (31%). Only 45.5% answered knowledge questions correctly. The adherence level in this study was 64.0%. The major reasons cited for non-adherence included being away from home (23.6%), forgetfulness (17.1%), busy schedule (14%), need to conceal medication (12.7%) and feeling better (11.6%).

Conclusion: Patients’ knowledge of ART and adherence to ARVs medicines were sub-optimal. Appropriate strategies to improve patients’ knowledge of ART and adherence to ARVs are recommended.

Author Biography

  • David Ufuoma Adje, Delta State University, Abraka, Nigeria,

    ASSOCIATE DEAN

References

UNAIDS Report on the Global AIDS epidemic. [online] Available from: www.unaids.org/en/resources/campaigns/globalreport2013/ [Accessed 7 June 2014].

UN Political Declaration on HIV/AIDS 2011. [online] Available from: www.avert.org/un-political-declaration-hivaids.htm [Accessed 7 June 2014].

Nigeria Global AIDS Response Progress Report 2014. Available at www.unaids.org/sites/default/files/country/.../NGA_narrative_report_2014.pdf.Accessed 16/5/2015

Federal Ministry of health Nigeria Integrated National Guidelines for HIV Prevention, Treatment and Care in Nigeria 2014. ISBN: 978-978-50455-6-7 .Available at http://www.hivpolicywatch.org/duremaps/data/guidelines/NigeriaARTguidelines2014.pdf.Accessed 16/3/15

Adherence to ART ,Available at http://aidsinfo.nih,gov,guidelines.htm .Accessed 6/9/15

Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002; 288:462-7.

Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA 2003; 261:3273-7.

Haynes RB, Mcdonald HP, Garg AX. (2002) Helping patients follow prescribed treatment: clinical complications. JAMA 2002; 288(22):2880-3.

Bangsberg, D R, Perry S, Charlebois E D, Clark R A, Robertson M, Zolopa AR, Moss A Non - adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001; 15(9):1181-1183.

Wagner JH, Justice AC, Chesney M, Sinclair G, Weissman S, Rodriguez-Barradas M. Patient- and Provider-reported adherence. J. Clin. Epidemiol. 2001; 54: Suppl. 1: S91-S98.

Yamane formula for calculating sample size [online] Available from: http://www.DumbLittleDoctor.com [Accessed 15/8/2015]

Knobel H, Alonso J, Casado J L, Collazaos J, Gonzalez J, and Ruiz I, Kindelan JM, Carmona A, Juega J. Ocampo A, GEEMA study group- Validation of a simplified medication adherence questionnaire in a large cohort of HIV- infected patients: the GEEMA study. AIDS 2002,mar 8;16(4):605-13

IBM Corp. IBM SPSS Statistics for windows, Version 21.0.Armonk.NY; IBM Corp.

Oyore JP, Mwanzo IJ, Orago AS, Odhiambo-Otieno GW Determinants of adherence to antiretroviral therapy (ART) among patients attending public and private health facilities in Nairobi, Kenya. Journal of AIDS and HIV Research 2013; 5(3): 70-74.

Yao P, Kpatcha T, Agnon B, Vincent PP, Innocent PG, Etienne KK. (2010) Knowledge and adherence to antiretroviral therapy amongst adult people living with HIV/AIDS treated in the health care centers of the association” Espoir Vie Togo” in Togo, West Africa. BMC Clinical Pharmacology 2010; 10:11

Iliyasu I, Kabir M, Abubakar I, Babashani M, Zubair Z. Compliance to antiretroviral therapy among AIDS patients in Amino Kano Teaching Hospital Kano. Nigeria J Med. 2005; 14(3): 290-294.

Oku AO, Owoaje ET, Ige OK, Oyo-ita A. Prevalence and determinants of adherence to HAART amongst PLHIV in a tertiary health facility in south-south Nigeria. BMC Infectious Diseases. 2013; 13:401.

Bello SI HIV/AIDS Patients’ Adherence to Antiretroviral therapy in Sobi Specialist Hospital, Ilorin, Nigeria. Global Journal of Medical Research 2011; XI (2): 16-21.

Olowookere SA, Fatiregun AA, Akinyemi JO, Bamgboye A. (2008) Prevalence and determinants of non- adherence to highly active antiretroviral therapy among people living with HIV/AIDS in Ibadan, Nigeria. J .Infect. Dev. Ctries 2008;2(5): 369-372

Agu KA, Okojie O, Oqua D, King RC, Omonaiye O, Onuoha C (2011) Medication Adherence and Risk factors for non-adherence among patients taking Highly Active Antiretroviral Therapy. West Afr. J. Pharm. 2011; 22(1): 19-26.

Amberbir A, Woldemichael K, Getachew S, Girma B, Deribe K. Predictors of adherence to antiretroviral therapy among HIV-infected persons: a prospective study in Southwest Ethiopia. BMC Public Health 2008; 8(265): 1-10.

Wakibi SN, Nga’ng’a ZW, Mbugua GG. Factors associated with non-adherence to highly active antiretroviral therapy in Nairobi, Kenya. AIDS Res.Ther.2011; 43: 1-8.

Talaam NC, Gatongi P, Rotich S. Factors affecting antiretroviral Drug Adherence among HIV/AIDS Adult Patients attending HIV/AIDS clinic at Moi Teaching and Referral Hospital, Eldoret, Kenya. East Afr. J. Public Health.2008; 5(2): 74-78.

Kleeberger C, Phair J Strathdee S, Detels R, Kingsley L, Jacobson L. Determinants of heterogeneous adherence to HIV antiretroviral therapies in the multicenter AIDS Cohort Study. J. Acquir. Immune Defic. Syndr. 2001; 26(1): 82-92.

Uzochukwu B, Onwujekwe O, Onoka A, Okoli C, Uguru N, Chukwuogo O. Determinants of non-adherence to subsidized antiretroviral treatment in Southeast Nigeria. Health Policy Plan. 2009, 24:189-196.

Afolabi MO, Ijadunola KT, Fatusi AO. (2009) Determinants of adherence to antiretroviral drugs among people living with HIV/AIDS in the Ife-Ijesa of Osun State, Nigeria. Afri J Prim Health Care Fam. Mad. 2009; I(1)1:6

Downloads

Published

2018-06-17

Issue

Section

Original Research